FindTrial
Sign In

Lymphatic mapping with SPECT-CT

OTHER2 trials

Sponsors

Canadian Cancer Trials Group, UNICANCER

Conditions

Head and NeckHead and Neck CancerHead and Neck CancersOropharyngeal CancerOropharyngeal CancersOropharyngeal CarcinomaOropharyngeal Squamous Cell Carcinoma

Phase 3

SPECT-CT Guided ELEctive Contralateral Neck Treatment for Patients With Lateralized Oropharyngeal Cancer
RecruitingNCT05451004
Canadian Cancer Trials GroupOropharyngeal Cancer
Start: 2023-02-10End: 2031-08-30Target: 510Updated: 2026-07-14

Unknown Phase

SPECT-CT Guided ELEctive Contralateral Neck Treatment in Lateralized Oropharyngeal Cancer
Not yet recruitingNCT07241273
UNICANCERHead and Neck, Head and Neck Cancer, Head and Neck Cancers +3
Start: 2026-09-01End: 2031-09-01Target: 128Updated: 2026-07-21

Related Papers

CCTG HN11: SPECT-CT guided elective contralateral neck treatment (SELECT) for patients with lateralized oropharyngeal cancer—A phase III randomized controlled trial.
Journal of Clinical Oncology2023-06-0110 citations